The DOI matches its Crossref record; 719 of the 719 references it cites were found in a registry or an index.
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Abstract
Background and Purpose—: This guideline provides an overview of the evidence on established and emerging risk factors for stroke to provide evidence-based recommendations for the reduction of risk of a first stroke. Methods—: Writing group members were nominated by the committee chair on the basis of their previous work in relevant topic areas and were approved by the American Heart Association (AHA) Stroke Council Scientific Statement Oversight Committee and the AHA Manuscript Oversight Committee. The writing group used systematic literature reviews (covering the time since the last review was published in 2006 up to April 2009), reference to previously published guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and when appropriate, formulate recommendations using standard AHA criteria ( Tables 1 and 2 ). All members of the writing group had the opportunity to comment on the recommendations and approved the final version of this document. The guideline underwent extensive peer review by the Stroke Council leadership and the AHA scientific statements oversight committees before consideration and approval by the AHA Science Advisory and Coordinating Committee. Results—: Schemes for assessing a person's risk of a first stroke were evaluated. Risk factors or risk markers for a first stroke were classified according to potential for modification (nonmodifiable, modifiable, or potentially modifiable) and strength of evidence (well documented or less well documented). Nonmodifiable risk factors include age, sex, low birth weight, race/ethnicity, and genetic predisposition. Well-documented and modifiable risk factors include hypertension, exposure to cigarette smoke, diabetes, atrial fibrillation and certain other cardiac conditions, dyslipidemia, carotid artery stenosis, sickle cell disease, postmenopausal hormone therapy, poor diet, physical inactivity, and obesity and body fat distribution. Less well-documented or potentially modifiable risk factors include the metabolic syndrome, excessive alcohol consumption, drug abuse, use of oral contraceptives, sleep-disordered breathing, migraine, hyperhomocysteinemia, elevated lipoprotein(a), hypercoagulability, inflammation, and infection. Data on the use of aspirin for primary stroke prevention are reviewed. Conclusion—: Extensive evidence identifies a variety of specific factors that increase the risk of a first stroke and that provide strategies for reducing that risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intense activity (an aerobic interval-training program 3 times per week for 12 weeks) was associated with a significant 35% improvement in left ventricular ejection fraction (EF) and decreases in pro-brain natriuretic peptide (40%), left ventricular end-diastolic volume (18%), and left ventricular end-systolic volume (25%) compared with control and endurance-training groups.”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“Intense activity (an aerobic interval-training program 3 times per week for 12 weeks) was associated with a significant 35% improvement in left ventricular ejection fraction (EF) and decreases in pro-brain natriuretic peptide (40%), left ventricular end-diastolic volume (18%), and left ventricular end-systolic volume (25%) compared with control and endurance-training groups.”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“Intense activity (an aerobic interval-training program 3 times per week for 12 weeks) was associated with a significant 35% improvement in left ventricular ejection fraction (EF) and decreases in pro-brain natriuretic peptide (40%), left ventricular end-diastolic volume (18%), and left ventricular end-systolic volume (25%) compared with control and endurance-training groups.”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“Intense activity (an aerobic interval-training program 3 times per week for 12 weeks) was associated with a significant 35% improvement in left ventricular ejection fraction (EF) and decreases in pro-brain natriuretic peptide (40%), left ventricular end-diastolic volume (18%), and left ventricular end-systolic volume (25%) compared with control and endurance-training groups.”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“RRs for hemorrhagic stroke were 1.01 (0.88–1.17) and 1.24 (0.99–1.54) for overweight and obese individuals, respectively.”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“Among participants with DM, the age- and sex-adjusted CVD incidence rate was 286.4 per 10 000 person-years in the earlier period and 146.9 per 10 000 person-years in the later period, a 35.4% decline.”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“HRs for DM as a predictor of incident CVD were not significantly different in the earlier (risk factor–adjusted HR, 2.68; 95% CI, 1.88–3.82) versus later (HR, 1.96; 95% CI, 1.44–2.66) period.34”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“Data from FHS show that despite improvements in CVD morbidity and mortality, DM continues to be associated with incremental CVD risk.”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“The metabolic syndrome is associated with increased healthcare use and healthcare-related costs among individuals with and without DM.”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“Overall, healthcare costs increase by ≈24% for each additional metabolic syndrome component present.34”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“People with both albuminuria/proteinuria and reduced eGFR are at particularly high risk for CVD, CVD outcomes, and death.34”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“Individuals who have a TIA and survive the initial high-risk period have a 10-year stroke risk of roughly 19% and a combined 10-year stroke, MI, or vascular death risk of 43% (4% per year).34”
From Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association (2013) · cites this paper as [34]
In the citing paper
“There are also other reports suggesting that the outcome of cerebral infarction that occurs during the course of treatment with statins is satisfactory866), and that cerebral infarction risk increases as a result of discontinuing statin treatment867).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [866]
Citations
Cites
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Flagged first, then by citations
Research works printed but not linked: 7
- Tournier-Lasserve E, Joutel A, Chabriat H . Clinical phenotypes and genetic data in 15 unrelated families. Neurology. 1995;45(suppl 4):A273.
- 10.1542/peds.114.s2.555 · DOI
- Prevalence of diabetes and impaired fasting glucose in adults—United States 1999–2000. MMWR Morb Mortal Wkly Rep. 2003;52:833–837. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5235a1.htm. Published September 5 2003. Updated April 7 2004. Accessed August 14 2010.
- Guide to Clinical Preventive Services: Report of the U. S. Preventive Services Task Force. Baltimore MD: Williams and Wilkins; 1996. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=hscps2ed1996&part=A19920. Accessed October 14 2010.
- Hanson MR, Hodgeman JR, Conomy JP . A study of stroke associated with prolapsed mitral valve. Neurology. 1978;23:341.
- Adams R . In: , Embury S , ed. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press;1994:599–621.
- Heart Disease and Stroke Statistics: 2009 Update. Dallas, TX: American Heart Association; 2009.
Cited by
Sorted by citations
Items 201–300 of 1,000
Șerban, M.-C., Sahebkar, A., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Muntner, P., Blaha, M. J., Andrica, F., Martin, S. S., Borza, C., et al. (2016) · Scientific Reports · doi:10.1038/srep19188 · Cited by 65
The Migraine–Stroke Connection
Lee, M. J., Lee, C., & Chung, C. (2016) · Journal of Stroke · doi:10.5853/jos.2015.01683 · Cited by 66
Haemoglobin management in acute brain injury
LeRoux, P. D. (2013) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32835eba43 · Cited by 61
Brigo, F., Lochner, P., Nardone, R., Manganotti, P., & Lattanzi, S. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.05.005 · Cited by 64
Sutcliffe, P. A., Connock, M. J., Gurung, T., Freeman, K., Johnson, S. A., Kandala, N., Grove, A., Gurung, B., Morrow, S., Stranges, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081970 · Cited by 62
Sheffler, L. R., Taylor, P. N., Gunzler, D. D., Buurke, J. H., IJzerman, M. J., & Chae, J. (2013) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2013.01.024 · Cited by 61
Kahle, L. E., Kelly, P. V., Eliot, K. A., & Weiss, E. P. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.04.009 · Cited by 61
Carotenoids as Potential Antioxidant Agents in Stroke Prevention: A Systematic Review
Bahonar, A., Saadatnia, M., Khorvash, F., Maracy, M. R., & Khosravi, A. (2017) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_112_17 · Cited by 61
Droste, D. W., Iliescu, C., Vaillant, M., Gantenbein, M., Bremaeker, N. D., Lieunard, C., Velez, T., Meyer, M., Guth, T., Kuemmerle, A., et al. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-147 · Cited by 61
Tobacco smoking in Egypt: a scoping literature review of its epidemiology and control measures
Fouda, S., Kelany, M. A., Moustafa, N., Abushouk, A. I., Hassane, A., Sleem, A. S., Mokhtar, O., Negida, A., & Bassiony, M. M. (2018) · Eastern Mediterranean Health Journal · doi:10.26719/2018.24.2.198 · Cited by 63
Yi, F., Ling, T.-Y., Lü, T., Wang, X.-L., Li, J., Claycomb, W. C., Shen, W.-K., & Lee, H.-C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.607952 · Cited by 60
Safety of hormonal contraceptives among women with migraine: A systematic review
Tepper, N. K., Whiteman, M. K., Zapata, L. B., Marchbanks, P. A., & Curtis, K. M. (2016) · Contraception · doi:10.1016/j.contraception.2016.04.016 · Cited by 59
Guan, L., Collet, J., Mazowita, G., & Claydon, V. E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00090 · Cited by 62
Corbett, D., Jeffers, M. S., Nguemeni, C., Gomez-Smith, M., & Livingston‐Thomas, J. M. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2014.12.002 · Cited by 63
Intracranial Arterial Stenosis
Carvalho, M., Oliveira, A., Azevedo, E. I., & de Bastos-Leite, A. J. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.06.006 · Cited by 58
Stein, R. A., Rockman, C. R., Guo, Y., Adelman, M. A., Riles, T. S., Hiatt, W. R., & Berger, J. S. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304161 · Cited by 58
A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach?
Brotons, C., Benamouzig, R., Filipiak, K. J., Limmroth, V., & Borghi, C. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0100-5 · Cited by 58
Differences in the role of black race and stroke risk factors for first vs recurrent stroke
Howard, G., D, B. M. K. M., Kleindorfer, D., McClure, L. A., Soliman, E. Z., Judd, S. E., Rhodes, J. D., Cushman, M., Moy, C. S., Sands, K. A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002376 · Cited by 58
Self-citationVisit-to-Visit Blood Pressure Variability in Alzheimer Disease
Lattanzi, S., Viticchi, G., Falsetti, L., Buratti, L., Luzzi, S., Provinciali, L., & Silvestrini, M. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000040 · Cited by 58
Iacoviello, L., Bonaccio, M., Cairella, G., Catani, M. V., Costanzo, S., D’Elia, L., Giacco, R., Rendina, D., Sabino, P., Savini, I., et al. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.12.010 · Cited by 60
Chronic Kidney Disease and Stroke
Husseini, N. E., Kaskar, O. B., & Goldstein, L. B. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.09.001 · Cited by 57
Self-citationThe Obesity Paradox in Stroke: Impact on Mortality and Short-term Readmission
Barba, R., Marco, J., Ruiz, J. R., Canora, J., Hinojosa, J., Plaza, S., & Zapatero, A. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.11.002 · Cited by 55
Avcı, A. Y., Lakadamyalı, H., Arıkan, S., Benli, S., & Toprak, M. K. (2015) · The Journal of Headache and Pain · doi:10.1186/1129-2377-16-9 · Cited by 57
Low‐Value Service Use in Provider Organizations
Schwartz, A. L., Zaslavsky, A. M., Landon, B. E., Chernew, M. E., & McWilliams, J. M. (2016) · Health Services Research · doi:10.1111/1475-6773.12597 · Cited by 59
Hong, K., Kim, S. H., Cha, D. H., & Park, H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011202 · Cited by 62
Monz, B. U., Connolly, S. J., Korhonen, M., Noack, H., & Pooley, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.059 · Cited by 56
Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation
Christiansen, C. B., Lip, G. Y. H., Lamberts, M., Gislason, G., Torp-Pedersen, C. T., & Olesen, J. B. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12297 · Cited by 56
Polonikov, A., Вялых, Е. К., Churnosov, M. I., Illig, T., Freidin, M. B., Васильева, О. В., Bushueva, O. Y., Николаевна, Р. В., Булгакова, И. В., & Solodilova, M. A. (2011) · Hypertension Research · doi:10.1038/hr.2011.213 · Cited by 55
Epidemiology, Pathophysiology, and Treatment of Hypertension in Ischaemic Stroke Patients
Hisham, N. M., & Bayraktutan, U. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.05.001 · Cited by 55
The obesity paradox and survivors of ischemic stroke.
Wohlfahrt, P., Lopez-Jimenez, F., Krajčoviechová, A., Jozífová, M., Mayer, O., Vaněk, J., Filipovský, J., Llano, E. M., & Cífková, R. (2015) · Journal of Stroke & Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.03.008 · Cited by 54
Impact of age on cerebrovascular dilation versus reactivity to hypercapnia
Coverdale, N. S., Badrov, M. B., & Shoemaker, J. K. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15626156 · Cited by 55
Song, Y., Xu, B. P., Xu, R., Tung, R., Frank, E., Tromble, W., Fu, T., Zhang, W., Yu, T., Zhang, C., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.07023 · Cited by 55
Management of carotid stenosis in women
Rango, P. D., Brown, M. M., Leys, D., Howard, V. J., Moore, W. S., Paciaroni, M., Ringleb, P. A., Rockman, C. R., & Caso, V. (2013) · Neurology · doi:10.1212/wnl.0b013e318296e952 · Cited by 54
Self-citationLiterature and Art Therapy in Post-Stroke Psychological Disorders
Eum, Y., & Yim, J. (2014) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.235.17 · Cited by 54
Starke, R. M., Ali, M., Jabbour, P. M., Tjoumakaris, S. I., Gonzalez, F., Hasan, D. M., Rosenwasser, R. H., Owens, G. K., Koch, W. J., & Dumont, A. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071954 · Cited by 55
Bell, C., LaCroix, A., Masaki, K., Hade, E., Manini, T., Mysiw, W. J., Curb, J., & Wassertheil-Smoller, S. (2013) · Journal of The American Geriatrics Society · doi:10.1111/jgs.12361 · Cited by 50
Hyun, S., Kwon, S., Cho, S., et al. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.07.024 · Cited by 54
Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes
Perreault, S., Yu, A., Côté, R., Dragomir, A., White‐Guay, B., & Dumas, S. (2012) · Neurology · doi:10.1212/wnl.0b013e3182749e56 · Cited by 52
Stroke in Patients With Peripheral Artery Disease
Kolls, B. J., Sapp, S. K., Rockhold, F. W., Jordan, J. D., Dombrowski, K. E., Fowkes, F. G. R., Mahaffey, K. W., Berger, J. S., Katona, B. G., Blomster, J., et al. (2019) · Stroke · doi:10.1161/strokeaha.118.023534 · Cited by 54
Udell, J. A., Opotowsky, A. R., Khairy, P., Silversides, C. K., Gladstone, D. J., O’Gara, P. T., & Landzberg, M. J. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.05.004 · Cited by 52
Lopez-Sendon, J. L., González‐Juanatey, J. R., Pinto, F. J., Castillo, J. J. C., Badimón, L., Dalmau, R., Torrecilla, E. G., López-Mínguez, J. R., Maceira, A. M., Pascual-Figal, D. A., et al. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.07.005 · Cited by 55
Ultrasonographic Markers of Vascular Risk in Patients with Asymptomatic Carotid Stenosis
Silvestrini, M., Altamura, C., Cerqua, R., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.5 · Cited by 52
The Impact of Mild Stroke on Participation in Physical Fitness Activities
Hildebrand, M. W., Brewer, M., & Wolf, T. (2011) · Stroke Research and Treatment · doi:10.1155/2012/548682 · Cited by 52
N-Acetylcysteine Attenuates Cisplatin-Induced Acute Kidney Injury by Inhibiting the C5a Receptor
Huang, S., You, J., Wang, K., et al. (2019) · BioMed Research International · doi:10.1155/2019/4805853 · Cited by 52
Harada, S., Fujita‐Hamabe, W., & Tokuyama, S. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11r04cr · Cited by 51
Zhang, L., He, Z., Zhang, Q., Wu, Y., Yang, X., Niu, W., Hu, Y., & Jia, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034453 · Cited by 52
Geomagnetic Storms Can Trigger Stroke
Feigin, V. L., Parmar, P. G. K., Barker-Collo, S. L., Bennett, D., Anderson, C. S., Thrift, A. G., Stegmayr, B., Rothwell, P. M., Giroud, M., Béjot, Y., et al. (2014) · Stroke · doi:10.1161/strokeaha.113.004577 · Cited by 53
Residential Proximity to High-Traffic Roadways and Poststroke Mortality
Wilker, E. H., Mostofsky, E., Lue, S.-H., Gold, D. R., Schwartz, J. D., Wellenius, G. A., & Mittleman, M. A. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.03.034 · Cited by 56
Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
Herrington, W. G., Haynes, R., Staplin, N., Emberson, J., Baigent, C., & Landray, M. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12281 · Cited by 51
Bushnell, C., & McCullough, L. D. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0762 · Cited by 52
Self-citationIncreased risk of ischaemic stroke among patients with multiple sclerosis
Tseng, C., Huang, W. ‐., Lin, C., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12598 · Cited by 51
Kotani, K., Șerban, M.-C., Penson, P. E., Lippi, G., & Banach, M. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2016.1188055 · Cited by 50
Mimicking oxygen delivery and waste removal functions of blood
Zhang, H., & Barralet, J. E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.02.001 · Cited by 50
Swallowing and Aspiration Risk: A Critical Review of Non Instrumental Bedside Screening Tests
Virvidaki, I. E., Nasios, G., Kosmidou, M. S., Giannopoulos, S., & Milionis, H. J. (2018) · Journal of Clinical Neurology · doi:10.3988/jcn.2018.14.3.265 · Cited by 54
Hypertension and Mild Cognitive Impairment
Sierra, C., Doménech, M., Camafort, M., & Coca, A. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0315-2 · Cited by 55
Xian, Y., Holloway, R. G., Smith, E. E., Schwamm, L. H., Reeves, M. J., Bhatt, D. L., Schulte, P. J., Cox, M., Olson, D. M., Hernandez, A. F., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.005620 · Cited by 49
Kao, C.-L., Cheng, Y., Leu, H., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00108 · Cited by 49
The equity of China’s emergency medical services from 2010–2014
Yan, K., Jiang, Y., Qiu, J., et al. (2017) · International Journal for Equity in Health · doi:10.1186/s12939-016-0507-5 · Cited by 49
Markišić, M., Pavlovic, A. M., & Pavlović, D. M. (2017) · BioMed Research International · doi:10.1155/2017/5489057 · Cited by 50
Chiang, M., Wu, H.-H., Shih, C.-J., Chen, Y., Kuo, S., & Chen, T.-L. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.07.020 · Cited by 49
Kidney stones may increase the risk of coronary heart disease and stroke
Peng, J., & Zheng, H. (2017) · Medicine · doi:10.1097/md.0000000000007898 · Cited by 49
Quality of stroke guidelines in low- and middle-income countries: a systematic review
Yaria, J. O., Gil, A. U., Makanjuola, A., Oguntoye, R. A., Miranda, J. J., Lazo-Porras, M., Zhang, P., Tao, X., Ahlgren, J. Á., Bernabé‐Ortiz, A., et al. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.21.285845 · Cited by 48
Migraine and Stroke: “Vascular” Comorbidity
Guidetti, D., Rota, E., Morelli, N., & Immovilli, P. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00193 · Cited by 46
Clinical and anatomic outcomes after carotid endarterectomy
Kang, J. L., Conrad, M. F., Patel, V. I., Mukhopadhyay, S., Garg, A., Cambria, M. R., LaMuraglia, G. M., & Cambria, R. P. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.10.059 · Cited by 48
TRPM7 in cerebral ischemia and potential target for drug development in stroke
Bae, C. Y.-J., & Sun, H. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.60 · Cited by 48
Bartels, S. L., van Knippenberg, R. J. M., Dassen, F. C. M., Asaba, E., Patomella, A.-H., Malinowsky, C., Verhey, F. R. J., & de Vugt, M. E. (2019) · Internet Interventions · doi:10.1016/j.invent.2019.100283 · Cited by 45
Nacu, A., Fromm, A., Sand, K. M., Waje‐Andreassen, U., Thomassen, L., & Næss, H. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12446 · Cited by 47
Hwang, M., Kwon, S.-S., Wi, J. H., Park, M., Lee, H., Park, J. S., Lee, Y.-S., Shim, E. B., & Pak, H. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.09.006 · Cited by 47
Racial Differences in the Effect of a Telephone-Delivered Hypertension Disease Management Program
Jackson, G. L., Oddone, E. Ž., Olsen, M. K., Powers, B. J., Grubber, J. M., McCant, F., & Bosworth, H. B. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2138-x · Cited by 46
A Systematic Literature Review of Risk Factors for Stroke in China
Huo, Y., Foody, J. M., Ji, L., Zhao, D. H., Wang, Y., Ma, L., Meng, H. J., Shiff, S., & Da-yi, H. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e3182748d37 · Cited by 47
Hira, R. S., GOSCH, K. L., Kazi, D. S., Yeh, R. W., Kataruka, A., Maddox, T. M., Shah, T., Jneid, H. M., Bhatt, D. L., & Virani, S. S. (2022) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.121.007979 · Cited by 48
Wang, Y., Zhao, R., Wang, B., Zhao, C., Zhu, B., & Xin, T. (2022) · Nutrients · doi:10.3390/nu14040777 · Cited by 51
Choi, J. C., Johnston, S. C., & Kim, A. S. (2014) · Stroke · doi:10.1161/strokeaha.114.006209 · Cited by 46
A New Paradigm for Primary Prevention Strategy in People with Elevated Risk of Stroke
Feigin, V. L., & Norrving, B. G. (2014) · International Journal of Stroke · doi:10.1111/ijs.12300 · Cited by 46
Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis
Tan, L., Barnhart, M., Zhang, J. H., Hu, R., Yin, Y., Cao, L., Feng, H., & Zhang, Y. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.12.002 · Cited by 46
Phytochemicals in Ischemic Stroke
Kim, J., Fann, D. Y., Seet, R. C. S., Jo, D., Mattson, M. P., & Arumugam, T. V. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8403-0 · Cited by 46
Wang, H., Zhang, X., Tomiyoshi, G., Nakamura, R., Shinmen, N., Kuroda, H., Kimura, R., Mine, S., Kamitsukasa, I., Wada, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23789 · Cited by 46
Dietary natural products as emerging lipoprotein(a)‐lowering agents
Momtazi‐Borojeni, A. A., Katsiki, N., Pirro, M., Banach, M., Al‐Rasadi, K., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28134 · Cited by 46
Association of Circulating Metabolites in Plasma or Serum and Risk of Stroke
Vojinović, D., Kalaoja, M., Trompet, S., Fischer, K., Shipley, M. J., Li, S., Havulinna, A. S., Perola, M., Salomaa, V. V., Yang, Q., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000011236 · Cited by 48
Bello, N. A., Lewis, E. F., Desai, A. S., Anand, I. S., Krum, H., McMurray, J. J. V., Olson, K. A., Solomon, S. D., Swedberg, K. B., van Veldhuisen, D. J., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.412 · Cited by 45
Uhm, J., Hwang, M., Song, J.-S., Lim, B., Kim, T., Joung, B., Kim, S. H., Oh, Y., Nam, G.-B., On, Y. K., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00792 · Cited by 44
Telomere Length: A Potential Biomarker for the Risk and Prognosis of Stroke
Tian, Y., Wang, S., Jiao, F., Kong, Q., Liu, C., & Wu, Y. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00624 · Cited by 48
Tułowiecka, N., Kotlęga, D., Prowans, P., & Szczuko, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207628 · Cited by 45
Holodinsky, J. K., Zerna, C., Malo, S., Svenson, L. W., & Hill, M. D. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(22)00222-5 · Cited by 45
Barber, C. E. H., Smith, A., Esdaile, J. M., Barnabe, C. C. M., Martin, L. O., Faris, P., Hazlewood, G. S., Noormohamed, R., Alvarez, N., Mancini, G. B. J., et al. (2014) · Arthritis Care & Research · doi:10.1002/acr.22419 · Cited by 49
The role of orexin in post-stroke inflammation, cognitive decline, and depression
Song, J., Kim, E., Kim, C. H., Song, H., & Lee, J. E. (2015) · Molecular Brain · doi:10.1186/s13041-015-0106-1 · Cited by 49
Obstructive Sleep Apnea as an Independent Stroke Risk Factor
King, S., & Cuellar, N. G. (2016) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0000000000000196 · Cited by 42
de Morais, V. A. C., Tourino, M. F. D. S., Almeida, A. C. D. S., Albuquerque, T. B. D., Linhares, R. C., Christo, P. P., Martinelli, P. M., & Scalzo, P. L. (2017) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2017.1373500 · Cited by 48
Gourdy, P., Bachelot, A., Catteau-Jonard, S., Chabbert‐Buffet, N., Christin‐Maître, S., Conard, J., Fredenrich, A., Gompel, A., Lamiche-Lorenzini, F., Moreau, C., et al. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.09.001 · Cited by 40
Cruse, B., Cysique, L. A., Markus, R., & Brew, B. J. (2012) · Journal of NeuroVirology · doi:10.1007/s13365-012-0092-3 · Cited by 46
Fonville, S., Zandbergen, A. A. M., Vermeer, S. E., Dippel, D. W. J., Koudstaal, P. J., & den Hertog, H. M. (2013) · Cerebrovascular Diseases · doi:10.1159/000353677 · Cited by 43
Thrombophilia testing in young patients with ischemic stroke
Pahus, S. H., Hansen, A. T., & Hvas, A. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.11.006 · Cited by 43
The 1027th target candidate in stroke: Will NADPH oxidase hold up?
Radermacher, K. A., Wingler, K., Kleikers, P. W. M., Altenhöfer, S., Hermans, J. J. R., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-4-11 · Cited by 43
Clinical Mimics: An Emergency Medicine-Focused Review of Stroke Mimics
Long, B., & Koyfman, A. (2016) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.09.021 · Cited by 44
Kern, S., Skoog, I. G., Östling, S., Kern, J., & Börjesson‐Hanson, A. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001288 · Cited by 43
Bousser, M. (2012) · Frontiers of Medicine · doi:10.1007/s11684-012-0178-6 · Cited by 44
Wu, J., Chen, S., Liu, L., Gao, X., Zhou, Y., Wang, C., Zhang, Q., Wang, A., Hussain, M., Sun, B., et al. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000206 · Cited by 42
McGrath, E. R., Kapral, M. K., Fang, J., Eikelboom, J. W., Conghaile, A. Ó., Canavan, M. D., & O'Donnell, M. J. (2012) · Stroke · doi:10.1161/strokeaha.112.654145 · Cited by 42
Zhang, W., Zeng, Y., Wang, F., et al. (2020) · Aging · doi:10.18632/aging.102752 · Cited by 42
Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial
Turan, T. N., Voeks, J. H., Chimowitz, M. I., Roldan, A., LeMatty, T., Haley, W. E., Lopes-Virella, M. F., Chaturvedi, S., Jones, M. R., Heck, D. V., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.030730 · Cited by 42
Self-citation
Metadata
- Authors
- Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., Hinchey, J. A., Howard, V. J., Jauch, E. C., Levine, S. R., Meschia, J. F., Moore, W. S., Nixon, J. V. (., & Pearson, T. A.
- Affiliations
- American Heart Association (US)
- ORCID
- Venue
- Stroke
- Published
- 2011-02
- Volume
- 42
- Issue
- 2
- Pages
- 517-584
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W4211201192
- Semantic Scholar
- 3d07af22ceda0b5c157f83800d855a75eb4ea554
- Cited by
- 1,306
- References
- 719
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 39 · 2023: 39 · 2022: 39 · 2021: 46 · 2020: 68 · 2019: 72 · 2018: 82 · 2017: 96 · 2016: 99 · 2015: 124 · 2014: 187 · 2013: 126 · 2012: 162
- FWCI
- 85.19
- Type
- journal article
- Language
- en
- Update notices
- correction (2011-02-01)
- Open access
- closed
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- primary prevention, stroke risk factors, risk assessment, modifiable risk factors, hypertension, atrial fibrillation, dyslipidemia, carotid artery stenosis, diabetes mellitus, obesity, aspirin, hyperhomocysteinemia, metabolic syndrome, alcohol consumption, sleep-disordered breathing, migraine, hypercoagulability, inflammation, infection, hormone replacement therapy, sickle cell disease, cigarette smoking
- MeSH terms
- American Heart Association, Health Personnel, Humans, Primary Prevention, Risk Factors, United States, Evidence-Based Medicine, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review